LifeVantage (NASDAQ:LFVN) Stock Price Up 12.2%

LifeVantage Corp (NASDAQ:LFVN)’s share price rose 12.2% on Thursday . The company traded as high as $12.90 and last traded at $12.48, approximately 248,142 shares traded hands during trading. An increase of 97% from the average daily volume of 126,045 shares. The stock had previously closed at $11.12.

Separately, ValuEngine cut LifeVantage from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st.

The business has a 50-day simple moving average of $11.69 and a two-hundred day simple moving average of $12.70. The company has a market capitalization of $155.12 million, a price-to-earnings ratio of 24.47 and a beta of 0.66.

A number of institutional investors have recently bought and sold shares of the business. Wells Fargo & Company MN raised its stake in shares of LifeVantage by 24.7% during the 2nd quarter. Wells Fargo & Company MN now owns 17,302 shares of the company’s stock worth $224,000 after buying an additional 3,422 shares in the last quarter. Two Sigma Advisers LP raised its stake in shares of LifeVantage by 35.9% during the 4th quarter. Two Sigma Advisers LP now owns 14,372 shares of the company’s stock worth $190,000 after buying an additional 3,800 shares in the last quarter. BlackRock Inc. raised its stake in shares of LifeVantage by 1.8% during the 4th quarter. BlackRock Inc. now owns 242,383 shares of the company’s stock worth $3,197,000 after buying an additional 4,223 shares in the last quarter. O Shaughnessy Asset Management LLC raised its stake in shares of LifeVantage by 10.1% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 51,497 shares of the company’s stock worth $736,000 after buying an additional 4,721 shares in the last quarter. Finally, Parametric Portfolio Associates LLC raised its stake in shares of LifeVantage by 19.2% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 30,284 shares of the company’s stock worth $393,000 after buying an additional 4,881 shares in the last quarter. 38.24% of the stock is owned by institutional investors.

LifeVantage Company Profile (NASDAQ:LFVN)

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.

Further Reading: What is channel trading?

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply